In early 2026, Boeing is in a complex "turnaround" phase. While the company's stock reached a two-year high of approximately $248 in January 2026, reflecting investor optimism, its financial health remains burdened by high leverage. Boeing carries a debt-to-EBITDA ratio of over 3x, which is significantly higher than its rival Airbus. However, there are strong signs of recovery: the company has a massive order backlog of over $636 billion and targets a free cash flow of $9–$10 billion annually by 2027. Production for the 737 MAX is ramping up toward 47 aircraft per month, and the 787 Dreamliner is targeting 10 per month. While 2026 is projected to be its first sustainably positive year for free cash flow since the MAX crisis, the company still faces challenges with 777X delays and high production costs.